Name: iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)
Brand: MBL Life Sciences
Availability: InStock

Related products

Shop all

iTAg Tetramer/APC - HLA-A*02:01 HPV (YMLDLQPET)MBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-PEMBL Life Sciences$1,610.00

HLA-A*02:01 Negative Tetramer-APCMBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-BV421MBL Life Sciences$1,726.00

Reviews 0

No reviews have been added for this product.

Reviews

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application	FC
Reactivity	Human
Conjugation	APC
Immunogen	HTLV-1
Peptide Sequence	LLFGYPVYV
Class	Class I
Sequence Location	11-19
MHC Allele	A*02:01

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)
Datasheet	iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV) Datasheet

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)
Datasheet	iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV) Datasheet

Citations for iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV) – 1 Found

Kozako, Tomohiro; Yoshimitsu, Makoto; Akimoto, Masaki; White, Yohann; Matsushita, Kakushi; Soeda, Shinji; Shimeno, Hiroshi; Kubota, Ryuji; Izumo, Shuji; Arima, Naomichi. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Human Immunology. 2011;72(11):1001-6. PubMed

Reviews 0

Reviews

iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)

Additional information

Reviews 0

iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)

Additional information

Specifications

Specifications

iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)

Additional information

iTAg Tetramer/APC - HLA-A*02:01 HTLV-1 (LLFGYPVYV)

Additional information

Specifications

Specifications